Showing results (331-340 of 343) with videos related to
Sort By:
Pageof 35
Journal for Immunotherapy of Cancer|February 16, 2021
Therapeutic depletion of CCR8<sup>+</sup> tumor-infiltrating regulatory T cells elicits antitumor immunity and synergizes with anti-PD-1 therapyHelena Van Damme, Bruno Dombrecht, Máté Kiss, et al.Science Immunology|September 29, 2023
Laboratory mice with a wild microbiota generate strong allergic immune responsesJunjie Ma, Egon Urgard, Solveig Runge, et al.Cancer Cell|October 2, 2020
The PD-1/PD-L1-Checkpoint Restrains T cell Immunity in Tumor-Draining Lymph NodesFloris Dammeijer, Mandy van Gulijk, Evalyn E Mulder, et al.EMBO Molecular Medicine|July 11, 2014
Targeting macrophage Histone deacetylase 3 stabilizes atherosclerotic lesionsMarten A Hoeksema, Marion Jj Gijbels, Jan Van den Bossche, et al.Science Immunology|May 12, 2023
LXR signaling controls homeostatic dendritic cell maturationVictor Bosteels, Sandra Maréchal, Clint De Nolf, et al.Cell Reports|January 27, 2021
Aspergillus fumigatus tryptophan metabolic route differently affects host immunityTeresa Zelante, Tsokyi Choera, Anne Beauvais, et al.Immunity|June 15, 2022
Indoleamine 2,3-dioxygenase 1 activation in mature cDC1 promotes tolerogenic education of inflammatory cDC2 via metabolic communicationMarco Gargaro, Giulia Scalisi, Giorgia Manni, et al.The Journal of Clinical Investigation|October 2, 2015
IDO1 suppresses inhibitor development in hemophilia A treated with factor VIIIDavide Matino, Marco Gargaro, Elena Santagostino, et al.Cancer Research|September 17, 2025
Depleting IL1R2+ Tumor-Infiltrating Regulatory T Cells with an ADCC-Prone Nanobody Construct Boosts the Efficacy of Anti-PD-1 ImmunotherapySana M Arnouk, Daliya Kancheva, Helena Van Damme, et al.Nature|June 17, 2014
Aryl hydrocarbon receptor control of a disease tolerance defence pathwayAlban Bessede, Marco Gargaro, Maria T Pallotta, et al.Pageof 35